| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815857 | Neuropharmacology | 2012 | 11 Pages |
Abstract
⺠Inhibition of PDE4B and GSK-3 in sub-threshold doses elicited antipsychotic effect. ⺠DISC1-Q31L decreased PDE4B activity and increased sensitivity to GSK-3 blocker. ⺠PDE4B and GSK-3 synergistically interact with each other via DISC1.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Tatiana V. Lipina, Min Wang, Fang Liu, John C. Roder,